RAD51B plays a vital role in homologous recombinational repair of DNA double-strand breaks to maintain cell genomic stability and is a promising candidate oncogene and biomarker for cancer diagnosis and prognosis (Nagathihalli and Nagaraju, 2011; Terasawa et al., 2014; Cheng et al., 2016). Here, RAD51B is linked to cancer.